Martis Capital Named to Inc.'s 2026 Founder-Friendly Investors List for Sixth Consecutive Year
News related to:Martis Capital · 1 min read
WASHINGTON and SAN FRANCISCO and MIAMI, Oct. 27, 2026 /CourierPR/ -- Martis Capital, a private equity firm exclusively focused on the middle market healthcare sector, has been named to Inc.’s 2026 Founder-Friendly Investors list for the sixth consecutive year. This recognition, which honors firms that work closely with entrepreneurs and remain engaged with the businesses they back, highlights Martis Capital’s commitment to supporting founder-led companies.
Of the 294 firms recognized this year, Martis Capital was one of 14 healthcare-exclusive private equity firms to earn this honor.
According to Martis Capital, since 2011, the firm has raised more than $2.2 billion from a global base of institutional clients to invest in the middle-market North American healthcare sector. This substantial capital has enabled the firm to support numerous healthcare companies through their growth stages.
Martis Capital received the Founder-Friendly Investors recognition on August 13, 2026, based on an evaluation covering the preceding 12-month period. The recognition was granted by Inc. without any influence or control from Martis Capital. The firm did not exercise any influence or control over the criteria used or the results generated by Inc. This recognition should not be construed as an endorsement or recommendation of Martis Capital by Inc., the ranking entity, or any regulatory authority.
The recognition reflects Martis Capital’s dedication to working closely with founders and supporting their companies through growth and beyond. As a founder-friendly capital partner for growth-oriented healthcare companies, Martis Capital has consistently demonstrated its commitment to the healthcare industry and the entrepreneurs within it. The firm’s approach to partnering with founders and supporting their companies through growth and beyond is a key factor in its continued success and recognition.
Martis Capital’s continued success and recognition underscore its commitment to the healthcare sector and its founders. The firm’s ability to navigate the complex regulatory, clinical, and operational landscape of healthcare has been a key factor in its consistent support of founder-led companies.